Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies
CONCLUSIONS: Patients with MAC of the rectum are associated with a lower pCR rate and tumor downstaging rate, higher incidence of local recurrence, and poorer DFS with neoadjuvant treatment.PMID:34334298 | DOI:10.1016/j.clcc.2021.06.004
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Jianwei Zhang Xiaoyu Xie Zehua Wu Huabin Hu Yue Cai Jianxia Li Jiayu Ling Miaomiao Ding Weiwei Li Yanhong Deng Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Colorectal Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Study